Oramed Pharmaceuticals Inc.
ORMP | NASDAQ
$4.75
+$0.05 (+1.06%)
Sep 22, 2026, 1:14 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Nov 29, 2021 | Q3 2021 Aug 30, 2021 | Q2 2021 May 30, 2021 | Q1 2021 Feb 27, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 15.25M | 13.2M | 45.95M | 52.18M | 15.8M | 74.52M | 54.42M | 42.1M | 84.75M | 18.58M | 9.06M | 5.47M | 6.77M | 24.1M | 40.46M | 33.2M | 29.89M | 27.97M | 31.88M | 77.25M | 57.41M | 33.81M |
Short-Term Investments | 846K | 52.64M | 79.95M | 82.51M | 82.14M | 56.13M | 87.51M | 100.2M | 67.98M | 158.02M | 152.99M | 169.57M | 143.43M | 129.63M | 115.26M | 126.35M | 104.02M | 113.64M | 118.66M | 16.9M | 12.23M | 22.98M |
Long-Term Investments | 87.37M | 199.4M | 93.74M | 79.74M | 56.61M | 9.53M | 10.91M | 21.07M | 29.59M | 25.09M | 56.37M | 53.47M | 3.52M | 2.7M | 2.7M | 2.7M | 684K | 1.96M | 4.13M | 6.69M | 7.29M | 3.14M |
Other Long-Term Assets | 174.31M | 48K | 2.52M | 3.21M | 2.57M | 4.3M | 34K | 32K | 30K | 36K | 34K | -55.16M | 33K | 31K | 24K | 25K | 25.23M | 25.18M | 25.1M | 25.04M | 22K | 22K |
Receivables | n/a | n/a | 4.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 37.32M | 2.31M | 2.74M | 1.43M | 1.09M | 832K | 1.29M | 474K | 533K | 501K | 537K | 666K | 769K | 1.42M | 1.39M | 623K | 958K | 1.95M | 1.8M | 1.2M | 2.59M | 683K |
Total Current Assets | 53.41M | 68.15M | 133.27M | 136.12M | 99.03M | 131.48M | 143.22M | 142.77M | 153.27M | 177.1M | 162.58M | 175.71M | 150.97M | 155.16M | 157.11M | 160.17M | 134.87M | 143.56M | 152.33M | 95.34M | 72.23M | 57.47M |
Property-Plant & Equipment | 1.15M | 1.25M | 1.34M | 1.43M | 3.48M | 2.23M | 1.11M | 1.2M | 1.33M | 1.43M | 1.57M | 1.69M | 1.79M | 1.89M | 1.81M | 1.54M | 1.51M | 1.53M | 889K | 932K | 949K | 1.02M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 262.83M | 200.7M | 97.59M | 84.38M | 62.66M | 16.06M | 12.06M | 22.31M | 30.95M | 26.56M | 57.97M | 55.19M | 5.34M | 4.62M | 4.53M | 4.27M | 27.42M | 28.66M | 30.12M | 32.66M | 8.26M | 4.19M |
Total Assets | 316.24M | 268.85M | 230.86M | 220.49M | 161.68M | 147.54M | 155.28M | 165.08M | 184.22M | 203.65M | 220.55M | 230.89M | 156.31M | 159.78M | 161.64M | 164.44M | 162.29M | 172.22M | 182.45M | 128M | 80.49M | 61.66M |
Account Payables | n/a | 481K | 443K | 560K | 715K | 509K | 789K | 5M | 3.48M | 1.27M | 551K | 2.56M | 828K | 4.06M | 2.18M | 4.21M | 3.48M | 3.31M | 4.76M | 2.61M | 2.86M | 3M |
Deferred Revenue | 1.71M | 1.47M | 1.35M | 986K | 1.24M | n/a | n/a | n/a | n/a | n/a | n/a | 4M | 4M | 674K | 1.34M | 2.02M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M |
Short-Term Debt | 249K | 268K | 285K | 271K | 264K | 181K | n/a | n/a | n/a | 32.03M | 51.01M | 75.61M | 236K | 242K | 247K | 228K | 233K | 237K | 130K | 130K | 129K | 139K |
Other Current Liabilities | 8.77M | 3.23M | 12.96M | 586K | 875K | 836K | 1.07M | 35K | n/a | 1K | 325K | -6.56M | -4.83M | -4.05M | -191K | -4.14M | -3.48M | -3.24M | -4.7M | -1.37M | -2.8M | -2.92M |
Total Current Liabilities | 10.73M | 10.56M | 19.09M | 6.12M | 3.69M | 5.49M | 5.69M | 5.27M | 3.73M | 33.56M | 53.21M | 78.18M | 1.07M | 4.97M | 5.75M | 6.53M | 6.42M | 6.32M | 7.66M | 6.68M | 5.75M | 5.93M |
Long-Term Debt | 484K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 389K | 488K | 564K | 647K | 672K | 744K | 871K | 374K | 403K | 431K | 469K |
Other Long-Term Liabilities | n/a | 238K | 314K | 38K | 36K | 33K | 90K | 4.1M | 100K | 103K | 102K | 88K | 93K | 85K | 82K | 82K | 81K | 121K | 144K | 145K | 180K | 197K |
Total Long-Term Liabilities | 40.03M | 20.01M | 12.03M | 12.04M | 4.41M | 2.15M | 4.25M | 4.29M | 4.34M | 4.38M | 4.44M | 4.49M | 4.59M | 4.66M | 4.74M | 4.77M | 2.84M | 3.68M | 4.1M | 4.8M | 5.55M | 6.28M |
Total Liabilities | 41.44M | 30.57M | 31.12M | 18.16M | 8.1M | 7.65M | 9.93M | 9.56M | 8.07M | 37.93M | 57.66M | 82.66M | 5.66M | 9.63M | 10.49M | 11.29M | 9.25M | 10M | 11.76M | 11.48M | 11.3M | 12.22M |
Total Debt | 733K | 761K | 825K | 860K | 912K | 301K | 372K | 429K | 486K | 32.56M | 51.62M | 76M | 724K | 806K | 894K | 900K | 977K | 1.11M | 504K | 533K | 560K | 608K |
Book Value | 274.8M | 238.28M | 199.74M | 202.33M | 153.58M | 139.89M | 145.35M | 155.52M | 176.15M | 165.72M | 162.89M | 148.23M | 150.66M | 150.15M | 151.16M | 153.15M | 153.04M | 162.22M | 170.69M | 116.52M | 69.2M | 49.44M |
Book Value Per Share | 6.47 | 5.68 | 4.71 | 4.73 | 3.60 | 3.39 | 3.64 | 3.80 | 4.24 | 3.99 | 4.02 | 3.66 | 3.75 | 3.75 | 3.88 | 3.92 | 3.94 | 4.19 | 4.65 | 3.89 | 2.31 | 1.83 |
Common Stock | 495K | 491K | 472K | 490K | 491K | 491K | 480K | 484K | 488K | 487K | 485K | 484K | 484K | 481K | 476K | 470K | 463K | 463K | 458K | 424K | 366K | 339K |
Retained Earnings | -6.97M | -85.12M | -123.44M | -122.58M | -170.97M | -184.26M | -176.62M | -166.43M | -146.81M | -156.02M | -157.56M | -170.89M | -167.67M | -166.48M | -163.08M | -154.54M | -147.48M | -136.95M | -122.74M | -114.85M | -108M | -102.79M |
Comprehensive Income | n/a | 0 | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 317.47M | 238.28M | 199.74M | 203.28M | 154.53M | 140.81M | 146.27M | 156.44M | 177.07M | 166.64M | 163.82M | 149.13M | 151.55M | 150.97M | 151.81M | 153.81M | 153.7M | 162.35M | 170.16M | 115.77M | 68.12M | 49.44M |
Total Investments | 88.21M | 252.04M | 173.68M | 162.25M | 138.75M | 65.66M | 98.42M | 121.27M | 97.58M | 183.11M | 209.36M | 223.04M | 146.96M | 132.33M | 117.96M | 129.05M | 104.7M | 115.6M | 122.79M | 23.59M | 19.52M | 26.12M |
Add to Watchlist
Select watchlists to add or remove ORMP